Serenoa repens induced erectile dysfunction: Underdiagnosis and phytovigilance
暂无分享,去创建一个
A. Vannacci | E. Gallo | F. Firenzuoli | G. Crescioli | V. Maggini | N. Lombardi | Francesco Sivelli
[1] G. Russo,et al. Pharmacological treatment of lower urinary tract symptoms in benign prostatic hyperplasia: consequences on sexual function and possible endocrine effects , 2020, Expert opinion on pharmacotherapy.
[2] E. Enioutina,et al. Spotlight Commentary: Why we need to pay attention to toxicity associated with herbal medicines , 2020, British journal of clinical pharmacology.
[3] P. Ravikumar,et al. An overview of herbal alternatives in androgenetic alopecia , 2019, Journal of cosmetic dermatology.
[4] M. Burkart,et al. [Influence of medical BPS treatment on sexual function]. , 2018, Der Urologe. Ausg. A.
[5] F. Montorsi,et al. Efficacy and Safety of Hexanic Lipidosterolic Extract of Serenoa repens (Permixon) in the Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: Systematic Review and Meta-analysis of Randomized Controlled Trials. , 2016, European urology focus.
[6] A. Vlietinck,et al. Assessment report on **Serenoa repens** (W. Bartram) Small, fructus , 2016 .
[7] A. Vannacci,et al. Pharmacovigilance of herb-drug interactions among preoperative patients. , 2014, Alternative therapies in health and medicine.
[8] A. Vannacci,et al. e-Phytovigilance for misleading herbal information. , 2013, Trends in pharmacological sciences.
[9] M. Irwig,et al. Persistent sexual side effects of finasteride for male pattern hair loss. , 2011, The journal of sexual medicine.
[10] E. Ernst,et al. Serenoa repens (Saw Palmetto) , 2009, Drug safety.
[11] T. Wilt,et al. Serenoa repens for benign prostatic hyperplasia. , 2000, The Cochrane database of systematic reviews.
[12] A. Hidalgo,et al. Spasmolytic Activity of a Lipidic Extract from Sabal serrulata Fruits: Further Study of the Mechanisms Underlying this Activity , 1996, Planta medica.